Analgesia elements (n= 10) | Expert quality score | Sedation elements (n= 10) | Expert quality score | Delirium elements (n= 4) | Expert quality score |
---|---|---|---|---|---|
Pain is regularly assessed | 1.0 (0) | Sedation is regularly assessed | 1.0 (0) | Delirium is regularly assessed | 1.7 (0.72) |
Pain is regularly documented | 1.0 (0) | Sedation is regularly documented | 1.0 (0) | Delirium is treated on a symptom-oriented basis | 1.9 (0.64) |
Validated pain scale is used to assess pain | 1.2 (0.56) | Validated sedation assessment scale is used | 1.1 (0.26) | Antipsychotic medications are included in the order set for the pharmacologic treatment of delirium | 1.7 (0.72) |
Self-report of pain is used to assess pain | 1.2 (0.56) | Sedation goal or endpoint is established for each patient | 1.0 (0) | The QT interval is monitored in patients receiving antipsychotics a | 1.8 (0.77) |
Therapeutic goal of analgesia is established | 1.1 (0.35) | The sedative dose is titrated to a defined endpoint | 1.0 (0) | Â | Â |
The analgesia goal is patient specific | 1.0 (0) | Sedation of agitated critically ill patients is started only after providing adequate analgesia | 1.4 (0.63) | Â | Â |
Analgesic medications are titrated based on the patient's goal and plan | 1.0 (0) | Sedation of agitated critically ill patients is started only after treating reversible physiologic causes | 1.4 (0.63) | Â | Â |
NSAIDs or acetaminophen should be provided as optional adjuncts to opioids in selected patients | 2.0 (0.76) | A sedation algorithm or protocol is used to guide the administration of sedation | 1.2 (0.41) | Â | Â |
Scheduled opioid doses or a continuous infusion are given preferentially over an as-needed regimen | 2.7 (1.1) | Daily interruption of sedation is performed in all patients who lack a contraindication | 1.1 (0.26) | Â | Â |
A patient-controlled analgesia device is preferred to deliver opioids if the patient is able to understand and operate the device | 2.1 (0.74) | The daily sedation interruption is explicitly linked to a spontaneous breathing trial | 1.4 (0.51) | Â | Â |